MARKET

NAOV

NAOV

Nanovibronix Inc
NASDAQ
0.8000
+0.0500
+6.67%
After Hours: 0.7510 -0.049 -6.13% 16:00 04/19 EDT
OPEN
0.7980
PREV CLOSE
0.7500
HIGH
0.8025
LOW
0.7451
VOLUME
33.46K
TURNOVER
0
52 WEEK HIGH
4.340
52 WEEK LOW
0.7000
MARKET CAP
2.23M
P/E (TTM)
-0.3773
1D
5D
1M
3M
1Y
5Y
NANOVIBRONIX: ON APRIL 10, GOT NASDAQ LETTER THAT CO DID NOT MEET MINIMUM BID PRICE REQUIRED FOR CONTINUED LISTING ON THE NASDAQ CAPITAL MARKET
Reuters · 4d ago
Weekly Report: what happened at NAOV last week (0408-0412)?
Weekly Report · 4d ago
NanoVibronix Inc Highlights 2023 Performance and Updates
TipRanks · 04/09 20:24
NanoVibronix Issues Letter To Stockholders
Our products continue to deliver impressive results with high patient satisfaction, with no adverse events. We are investing in sales improvement and long-term opportunities with all of our products. The company is committed to its strategic vision of developing, improving and commercializing our therapies and products.
Benzinga · 04/09 12:55
Financial Report: Comprehensive Overview of Preferred and Common Stock Members
Press release · 04/08 23:15
Weekly Report: what happened at NAOV last week (0401-0405)?
Weekly Report · 04/08 10:40
Weekly Report: what happened at NAOV last week (0325-0329)?
Weekly Report · 04/01 10:39
NanoVibronix signs agreement with Veranex
NanoVibronix, Inc. Enters into an agreement with Veranex to assist with the development of the company’s next generation UroShield and PainShield products. The company will provide certain research and development services to the company. Healthcare NanoVbronix signs agreement withVeranex.
Seeking Alpha · 03/28 13:39
More
About NAOV
NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Webull offers NanoVibronix Inc stock information, including NASDAQ: NAOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAOV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAOV stock methods without spending real money on the virtual paper trading platform.